รศ.ธีระ พิรัชวิสุทธิ์

Assoc. Prof.TEERHA PIRATVISUTH

---

E-mail:

This email address is being protected from spambots. You need JavaScript enabled to view it.

Education

• 1997 อนุมัติบัตร (อายุรศาสตร์โรคระบบทางเดินอาหาร) มหาวิทยาลัยสงขลานครินทร์, Thailand

Publication

• Teerha Piratvisuth. 2021. "Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients". CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 12 (2) : 1-7
• Teerha Piratvisuth. 2022. "Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)". Clinical Gastroenterology and Hepatology, 20 (4) : 784-793
• Teerha Piratvisuth. 2021. "Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa". CLINICS IN LIVER DISEASE, 25 (4) : 741-762
• Teerha Piratvisuth. 2021. "ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization". Asian Pacific Journal of Cancer Prevention, 22 (11) : 3685-3692
• Teerha Piratvisuth. 2022. "Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels". Journal of Hepatology, 76 (5) : 1042-1050
• Teerha Piratvisuth. 2022. "Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up". Frontiers in Medicine, 9 (24 Article number : 859430) : 1-9
• Teerha Piratvisuth. 2023. "FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE". Frontiers in Medicine, 10 (Article number : 1077842) : 1-10
• Teerha Piratvisuth. 2022. "Diagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study". World Journal of Surgical Oncology, 20 (Article number : 215) : 1-8
• Teerha Piratvisuth. 2022. "Decision-Making Scoring System for the Repetition of Conventional Transarterial Chemoembolization in Patients With Inoperable Hepatocellular Carcinoma". Clinical and translational gastroenterology, 13 (7 Article number : e005061) : 1-10
• Teerha Piratvisuth. 2022. "Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients". BMC Gastroenterology, 22 (1 Article number : 159) : 1-8
• Teerha Piratvisuth. 2021. "Alcohol-Associated Liver Disease: East Versus West". Clinical Liver Disease , 16 (6) : 231-235
• Teerha Piratvisuth. 2023. "Lower pre-treatment hbv dna levels are associated with better off-treatment outcomes after Nucleo(S)Tide analogue withdrawal in patients with hbeag negative chronic hepatitis B: A multicenter cohort study". JHEP Reports, 5 (8) : 1-8
• Teerha Piratvisuth. 2023. "The efficacy of branched-chain amino acid granules to restore phagocytic activity in cirrhosis patients, a randomized controlled trial". Frontiers in Nutrition, 10 (Article number :1142206) : 1-9
• Teerha Piratvisuth. 2023. "Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study". Vaccines, 11 (9 Article number : 1455) : 1-15
• Teerha Piratvisuth. 2024. "HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy". Gastroenterology, 166 (1) : 168-177
• Teerha Piratvisuth. 2024. "Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B". Diagnostics, 14 (13 Article number : 1325) : 1-11
• Teerha Piratvisuth. 2024. "Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region". Scientific Reports, 14 (Article number : 19544) : 1-10
• Teerha Piratvisuth. 2025. "Coexisting steatotic liver disease is not associated with long-term liver-related events in patients with chronic hepatitis B". Gastroenterology Report, 13 (-) : goaf013-goaf013

Interest